Neeta Garg

Dr. Neeta Garg


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NGNeeta Garg
Neeta Garg
EPElizabeth Jordan Padron
Elizabeth Jordan Padron
KRKottil W. Rammohan
Kottil W. Rammohan
CGCourtney Frances Goodman
Courtney Frances Goodman
Bruton’s tyrosine kinase (BTK) is an important protein belonging to the tyrosine kinase family that plays a key role in the intracellular signaling and proliferation, migration, and survival of normal and malignant B-lymphocytes and myeloid cells. Understanding the role of BTK in the B-cell signaling pathway has led to the development of BTK inhibitors (BTKi) as effective therapies for malignancies of myeloid origin and exploration as a promising therapeutic option for other cancers. Given its central function in B-cell receptor signaling, inhibition of BTK is an attractive approach for the treatment of a wide variety of autoimmune diseases that involve aberrant B-cell function including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). Here, we review the role of BTK in different cell signaling pathways, the development of BTKi in B-cell malignancies, and their emerging role in the treatment of MS and other autoimmune disorders.

1 July 2007 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
NGNeeta Garg
Neeta Garg
RZRobert Zivadinov
Robert Zivadinov
MRMurali Ramanathan
Murali Ramanathan
IVIrene Vasiliu
Irene Vasiliu
JLJaclyn Locke
Jaclyn Locke
BWBianca Weinstock-Guttman
Bianca Weinstock-Guttman